国产成人愉拍精品|亚洲中文字幕va毛片|亚洲成人在线免费观看|国产日韩欧美另类制服丝袜|久久久久国产精品免费网站|亚洲国产成人久久精品图片|无码人妻视频一区二区三区免|亚洲AV无码成人网站久久精品

寧波亞川生物醫(yī)藥有限公司
行業(yè)動(dòng)態(tài)
EU將在6個(gè)月內(nèi)實(shí)施藥品識(shí)別標(biāo)準(zhǔn)

Identification of Medicinal Products Standards will apply in six Months
藥品識(shí)別標(biāo)準(zhǔn)將在6個(gè)月內(nèi)實(shí)施

Over the last couple of years the European Health Authorities in conjunction with the International Standards Organization (ISO) have been developing a set of global data standards referred to as Identification of Medicinal Products (IDMP). 
在過(guò)去幾年間,歐洲衛(wèi)生管理局與國(guó)際標(biāo)準(zhǔn)組織(ISO)一起開(kāi)發(fā)了一系列的全球數(shù)據(jù)標(biāo)準(zhǔn),被稱為藥品識(shí)別(IDMP)標(biāo)準(zhǔn)。

The Identification of Medicinal Products (IDMP) standards were developed in response to a worldwide demand for internally harmonized specifications for medicinal products. The EU is the first to implement these standards, and the other ICH regions will follow. The pharma sector must comply with IDMP standards in the EU region starting July 2016. Following the EU, the other ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use) countries will then begin their own adoption processes to ensure global compliance. 
藥品識(shí)別(IDMP)標(biāo)準(zhǔn)在根據(jù)全球藥品協(xié)調(diào)規(guī)范要求開(kāi)發(fā)的。EU是第一個(gè)實(shí)施這些標(biāo)準(zhǔn)的地區(qū),其它ICH地區(qū)將隨后實(shí)施。自2016年7月起,EU地區(qū)的藥品部分必須遵守IDMP標(biāo)準(zhǔn),其它ICH國(guó)家之后要啟動(dòng)自己國(guó)家的采用流程,確保全球符合性。

Once the IDMP standards are implemented globally, detailed information about all medicinal products worldwide will, for the first time, be available in a consistent format. This provides regulators with the means of easily comparing product data across regions and with different manufacturers and marketing authorisation holders. This increased transparency will drive numerous patient safety initiatives. It also paves the way for the future roll-out of patient-centric initiatives such as 'e-prescriptions'. 
一旦IDMP標(biāo)準(zhǔn)在全球?qū)嵤?,所有全球藥品詳?xì)信息將首次以統(tǒng)一格式讓人們獲取。這使得法規(guī)工作者、不同生產(chǎn)商和上市許可持有人能夠很容易地將不同地區(qū)的藥品數(shù)據(jù)進(jìn)行比較。這種方式增加的透明度將保護(hù)無(wú)數(shù)患者的安全。它還會(huì)為未來(lái)全面推行患者自主中心,如“電子處方”鋪平道路。

Adopting the IDMP standard should not only help to achieve regulatory compliance but wants also improve internal business process efficiencies, as well as increase effectiveness between business functions and with external partners, truly enabling a task to value strategy. 
采用IDMP標(biāo)準(zhǔn)不僅能幫助達(dá)到法規(guī)符合性,還可以改善國(guó)際業(yè)務(wù)進(jìn)度有效性,以及增加業(yè)務(wù)功能和外部伙伴之間的有效性,真正將任務(wù)推進(jìn)成為一個(gè)產(chǎn)生價(jià)值的策略。

返回主目錄
 
點(diǎn)擊這里給我發(fā)消息
在線客服01
點(diǎn)擊這里給我發(fā)消息
在線客服02
點(diǎn)擊這里給我發(fā)消息
在線客服03